Assignee
ANNEXON INC
US·13 granted patents·21 pending applications·52 citations·filing 2014–2025
Top patents by PatentIndex Score
34 records- 0196US10927167B2Anti-complement factor C1Q antibodies and uses thereofANNEXON INC·Filed 2020·Granted Feb 23, 2021·4 cites·19 claims
- 0292US11649279B2Anti-complement factor C1Q antibodies and uses thereofANNEXON INC·Filed 2021·Granted May 16, 2023·2 cites·21 claims
- 0392US10723788B2Anti-complement factor C1q Fab fragments and uses thereofANNEXON INC·Filed 2016·Granted Jul 28, 2020·6 cites·20 claims
- 0492US10590190B2Anti-complement factor C1q antibodies and uses thereofANNEXON INC·Filed 2019·Granted Mar 17, 2020·8 cites·22 claims
- 0592US9708394B2Anti-complement factor C1q antibodies and uses thereofANNEXON INC·Filed 2016·Granted Jul 18, 2017·10 cites·28 claims
- 0691US10316081B2Humanized anti-complement factor C1Q antibodiesANNEXON INC·Filed 2015·Granted Jun 11, 2019·10 cites·30 claims
- 0791US10227398B2Anti-complement factor C1q antibodies and uses thereofANNEXON INC·Filed 2017·Granted Mar 12, 2019·8 cites·30 claims
- 0890US11999779B2Anti-complement factor C1q Fab fragments and uses thereofANNEXON INC·Filed 2020·Granted Jun 4, 2024·2 cites·19 claims
- 0986US12534522B2Anti-complement factor C1q antibodies and uses thereofANNEXON INC·Filed 2023·Granted Jan 27, 2026·0 cites·23 claims
- 1084US11814404B2Inhibitors of complement factors and uses thereofANNEXON INC·Filed 2021·Granted Nov 14, 2023·2 cites·48 claims
- 1182US2025002567A1Anti-complement factor c1q fab fragments and uses thereofANNEXON INC·Filed 2024·Application pending·0 cites
- 1280US2024025974A1Humanized anti-complement factor c1q antibodies and uses thereofANNEXON INC·Filed 2023·Application pending·0 cites
- 1374US2026070932A1Inhibitors of complement factors and uses thereofANNEXON INC·Filed 2025·Application pending·0 cites
- 1470US2021115119A1Humanized anti-complement factor c1q antibodies and uses thereofANNEXON INC·Filed 2020·Application pending·0 cites
- 1567US2024083989A1Compositions and methods for treating brain injuryANNEXON INC·Filed 2023·Application pending·0 cites
- 1666US12509474B2Inhibitors of complement factors and uses thereofANNEXON INC·Filed 2023·Granted Dec 30, 2025·0 cites·36 claims
- 1764US2025313614A1Compositions and methods for treating ocular diseasesANNEXON INC·Filed 2023·Application pending·0 cites
- 1862US2019315845A1Humanized anti-complement factor c1q antibodies and uses thereofANNEXON INC·Filed 2019·Application pending·0 cites
- 1960US12486322B2Anti-complement factor C1q antibodies with single binding arms and uses thereofANNEXON INC·Filed 2022·Granted Dec 2, 2025·0 cites·12 claims
- 2060US2025074973A1Compositions and methods for treating huntington’s diseaseANNEXON INC·Filed 2022·Application pending·0 cites
- 2160US2025313615A1Compositions and methods for treating lupus nephritisANNEXON INC·Filed 2023·Application pending·0 cites
- 2258US2024059765A1Compositions and methods for treating ocular diseasesANNEXON INC·Filed 2021·Application pending·0 cites
- 2356US2016090425A1Anti-complement factor c1s antibodies and uses thereofANNEXON INC·Filed 2014·Application pending·0 cites
- 2455US2016159890A1Methods of treatment for alzheimer's disease and huntington's diseaseANNEXON INC·Filed 2016·Application pending·0 cites
- 2553US12522619B2Inhibitors of complement factors and uses thereofANNEXON INC·Filed 2023·Granted Jan 13, 2026·0 cites·39 claims
- 2652US2025230225A1Compositions and methods for treating muscular dystrophyANNEXON INC·Filed 2022·Application pending·0 cites
- 2752US2023391858A1Compositions and methods for treating blood disordersANNEXON INC·Filed 2021·Application pending·0 cites
- 2849US2024109957A1Compositions and methods for treating blood disordersANNEXON INC·Filed 2020·Application pending·0 cites
- 2948US2016053023A1Methods of treatment for neuromyelitis opticaANNEXON INC·Filed 2014·Application pending·0 cites
- 3047US2020140533A1Compositions and methods for treating brain injuryANNEXON INC·Filed 2019·Application pending·0 cites
- 3143US2016326237A1Methods of treatment for guillain-barre syndromeANNEXON INC·Filed 2015·Application pending·0 cites
- 3241US2019151414A1Anti-complement factor c4/c4b antibodies and uses thereofANNEXON INC·Filed 2017·Application pending·0 cites
- 3338US2019161535A1Compositions and methods for treating spinal muscular atrophyANNEXON INC·Filed 2017·Application pending·0 cites
- 3437US2017081700A1Methods for screening for inhibitors of complement serine proteasesANNEXON INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ANNEXON INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →